Dexcom Inc
Dexcom Inc (DXCM) Straddle
DXCM straddle scan found 253 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 50.1%.
Read more
Trading a DXCM straddle lets you take a pure volatility position on Dexcom Inc without committing to a direction. Dexcom Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate DXCM straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on DXCM profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Dexcom Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the DXCM straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system.
The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the DXCM straddle is the cleanest expression of that view. Our scanner prices every DXCM straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a DXCM straddle into a catalyst or short a DXCM straddle to harvest decay, the options straddle setups that matter are all in one place.
| Dec 18, 2026 | 135.00 | $46.18 | 88 | 7% | 50.1% | $181.18 | $88.83 | 0 |
| Jan 15, 2027 | 135.00 | $46.48 | 116 | 7% | 49.7% | $181.48 | $88.53 | 0 |
| Jan 15, 2027 | 130.00 | $41.65 | 116 | 7% | 49.3% | $171.65 | $88.35 | 0 |
| Dec 18, 2026 | 130.00 | $41.50 | 88 | 7% | 49.2% | $171.50 | $88.50 | 0 |
| Oct 16, 2026 | 98.00 | $9.45 | 25 | 7% | 49.1% | $107.45 | $88.55 | 0 |
| Sep 25, 2026 | 95.00 | $5.93 | 4 | 7% | 49.0% | $100.93 | $89.08 | 1 |
| Dec 18, 2026 | 120.00 | $31.60 | 88 | 7% | 49.0% | $151.60 | $88.40 | 0 |
| Nov 20, 2026 | 120.00 | $31.43 | 60 | 7% | 48.9% | $151.43 | $88.58 | 0 |
| Dec 18, 2026 | 125.00 | $36.63 | 88 | 7% | 48.9% | $161.63 | $88.38 | 0 |
| Mar 19, 2027 | 135.00 | $47.45 | 179 | 7% | 48.5% | $182.45 | $87.55 | 0 |
As of September 22, 2026
Find the right straddle before volatility moves
Track DXCM straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→